Search for New Antineoplastic Agents Based on Structural Modifications of Steroidal 5α-Reductase, 17β-Hydroxysteroid Dehydrogenase, and 17α-Hydroxylase/17,20-Lyase Inhibitors
November 2025
in “
Russian Journal of Oncology
”
TLDR Modifying steroidal inhibitors shows promise for developing new cancer treatments.
This review explores the optimization of steroidal inhibitors targeting 5α-reductase, 17β-hydroxysteroid dehydrogenase, and 17α-hydroxylase/17,20-lyase to develop new antineoplastic agents. It presents the structures of 209 new compounds and evaluates their therapeutic potential through laboratory and preclinical data. The findings suggest that structural modifications of these steroidal inhibitors are promising for creating new cancer treatments. The review is based on 92 publications sourced from six databases, focusing on existing inhibitors and excluding non-steroidal ones.